CurrentUnitedHealthcarePolicy 2025R8015B

Reimbursement for prostate biopsy pathology

Governs UnitedHealthcare Commercial and Individual Exchange reimbursement methodology for pathological examination and coding of prostate biopsy services billed on CMS-1500 or UB04; affects all network and non‑network physicians, qualified health care professionals, and outpatient facilities.

Policy Summary

PayerUnitedHealthcare

PolicyReimbursement for prostate biopsy pathology

Policy CodePolicy 2025R8015B

Change TypeNo material change

Effective Date

Next Review Date

Key ActionLimit pathology reimbursement to up to twelve core extended samplings and reimburse G0416 only once per date of service.

SourceLink

POLICY UPDATE CHANGES

No material clinical or coverage changes in this revision.

up to 12 coresprostate biopsy cores considered for pathology reimbursement

88305listed surgical pathology CPT code

G0416 once per dateG0416 frequency limit

applies to allapplies to all products

Coverage Criteria

Policy Summary

PayerUnitedHealthcare

PolicyReimbursement for prostate biopsy pathology

Policy CodePolicy 2025R8015B

Change TypeNo material change

Effective Date

Next Review Date

Key ActionLimit pathology reimbursement to up to twelve core extended samplings and reimburse G0416 only once per date of service.

SourceLink

On This Page

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

Covered when ALL of the following are met:

ALL of the following

Pathological examination reimbursed for tissue from prostate biopsy involving up to twelve core extended samplings when performed as follow-up to abnormal PSA results, the presence of a palpable nodule on digital rectal examination, or suspicious radiologic findings.
Twelve core extended samplings defined as six individual units (two core samples per vial; one vial = one unit).
Operational definition: one vial equals one unit; two cores per vial equals one unit
The twelve core extended samplings limitation is applicable across all billing and/or rendering providers for the same member on the same date of service.

ALL of the following

Prostate needle biopsy procedure code G0416 reimbursed only once per date of service.
The once-per-date-of-service limitation for G0416 is applicable across all billing and/or rendering providers for the same member on the same date of service.

Apply limits across billing and rendering providers; do not duplicate reimbursement for same member and date of service.

Coding and Code Guidance

Surgical pathology of biopsyCPTCovered

88305

Surgical pathology, gross and microscopic examination

Prostate needle biopsyHCPCSCovered

G0416

Prostate biopsy, single or multiple, including imaging guidance and placement of needle or probe

G0416 frequency guidancemixed

G0416

Reimbursed only once per date of service across all billing and/or rendering providers for the same member

Twelve core extended samplings — coding threshold

DefinitionSix individual units equals twelve core extended samplings (two core samples per vial; one vial = one unit).

Unit interpretationOne vial contains two core samples and is counted as one unit toward the six-unit limit.

Sampling limit (actionable)Reimbursement limited to six individual units (equivalent to twelve core extended samplings) — highlight for provider billing and specimen submission.

Provider Actions and Billing Rules

Billing Rule

Pathology reimbursement limited to up to 12 cores

UnitedHealthcare will only consider reimbursement of pathological examination of tissue obtained from a prostate biopsy involving up to twelve core extended samplings when performed as a follow up to abnormal PSA results, the presence of a palpable nodule on digital rectal examination, or suspicious radiologic findings.

Limit applies to pathological examination of prostate biopsy specimens.
Twelve core extended samplings defined as six individual units (two core samples per vial; one vial = one unit).

Billing Rule

G0416 reimbursed once per date of service

UnitedHealthcare will only consider reimbursement of the prostate needle biopsy procedure code G0416 once per date of service.

G0416 reimbursed only once per date of service across billing and rendering providers for the same member.

OpenPayer

Reimbursement for prostate biopsy pathology

Coverage Criteria

Coding and Code Guidance

Provider Actions and Billing Rules

Definitions